Madrigal Pharmaceuticals (MDGL) net assets (shareholders' equity)

Net assets · fiscal 2025
$602.69M

Madrigal Pharmaceuticals (MDGL) had net assets of $602.69M at the end of fiscal 2025 (December 31, 2025). That is 20.1% lower than the $754.38M of fiscal 2024. Figures as of 18 Nov 2026, 19:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$602.69M
Change on fiscal 2024
−20.1%
Growth, 5 years
+20.2% a year
Highest on record
$754.38Mfiscal 2024
Lowest on record
$36.41Mfiscal 2016
Fiscal years on record
112012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Madrigal Pharmaceuticals net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 20.2% a year. Across the 11 fiscal years on record (2012–2025), the highest was $754.38M in fiscal 2024 and the lowest $36.41M in fiscal 2016.

History · 11 fiscal years

Net assets by fiscal year

Madrigal Pharmaceuticals net assets (shareholders' equity), year by year

Madrigal Pharmaceuticals (MDGL) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$602.69M 20.1% down
2024$754.38M 86.1% up
2023$405.33M 105.3% up
2022$197.39M 0.7% up
2021$196.11M 18.3% down
2020$239.97M 42.4% down
2019$416.57M 12.7% down
2018$476.98M 161.7% up
2017$182.26M 400.6% up
2016$36.41M—
2012$75.07M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

More on MDGL

Madrigal Pharmaceuticals, figure by figure

Madrigal Pharmaceuticals (MDGL) overview: price, valuation and scorecardAll health care companies by market value

Madrigal Pharmaceuticals net assets (shareholders' equity): questions and answers

What are Madrigal Pharmaceuticals's net assets?

Madrigal Pharmaceuticals (MDGL) had net assets of $602.69M at the end of fiscal 2025 (December 31, 2025). That is 20.1% lower than the $754.38M of fiscal 2024.

What is the growth rate of Madrigal Pharmaceuticals's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 20.2% a year.

What are the highest and lowest net assets figures on record for Madrigal Pharmaceuticals?

Across the 11 fiscal years on record (2012–2025), the highest was $754.38M in fiscal 2024 and the lowest $36.41M in fiscal 2016.

How is Madrigal Pharmaceuticals's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Madrigal Pharmaceuticals it is on record here for 11 fiscal years, 2012 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Madrigal Pharmaceuticals (MDGL) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/MDGL/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.